Status:
RECRUITING
18F-FDG PET/CT Guided Reduced-dose Radiotherapy for Nasopharyngeal Carcinoma
Lead Sponsor:
Taizhou Hospital
Collaborating Sponsors:
Taizhou Enze Medical Center Group
Taizhou Cancer Hospital
Conditions:
Nasopharyngeal Carcinoma
Eligibility:
All Genders
18-80 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to explore whether 18F-FDG PET/CT guided reduced-dose radiotherapy would maintain survival outcomes in nasopharyngeal carcinoma (NPC) patients.
Detailed Description
Enrolled patients with complete metabolic response (CMR) and more than 70% partial metabolic response (PMR) according to PERCIST criteria at the 25th fraction will receive intensity modulated radiatio...
Eligibility Criteria
No eligibility criteria provided.
Key Trial Info
Start Date :
January 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
June 30 2029
Estimated Enrollment :
93 Patients enrolled
Trial Details
Trial ID
NCT04813705
Start Date
January 1 2022
End Date
June 30 2029
Last Update
February 21 2023
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Taizhou Central Hospital
Taizhou, Zhejiang, China, 317000
2
Taizhou Hospital
Taizhou, Zhejiang, China, 317000
3
Taizhou Cancer Hospital
Taizhou, Zhejiang, China, 317500
4
Taizhou Enze Medical Center(Group) Enze Hospital
Taizhou, Zhejiang, China, 318050